Skip to main content
Cell Adhesion & Migration logoLink to Cell Adhesion & Migration
. 2009 Jan-Mar;3(1):71–76. doi: 10.4161/cam.3.1.7511

Huntingtin associated protein 1 and its functions

Linda Lin-yan Wu 1,, Xin-Fu Zhou 1,
PMCID: PMC2675152  PMID: 19262167

Abstract

Huntington disease (HD) is caused by a polyglutamine expansion in the protein huntingtin (Htt). Several studies suggest that Htt and huntingtin associated protein 1 (HAP1) participate in intracellular trafficking and that polyglutamine expansion affects vesicular transport. Understanding the function of HAP1 and its related proteins could help elucidate the pathogenesis of HD. The present review focuses on HAP1, which has proved to be involved in intracellular trafficking. Unlike huntingtin, which is expressed ubiquitously throughout the brain and body, HAP1 is enriched in neurons, suggesting that its dysfunction could contribute to the selective neuropathology in HD. We discuss recent evidence for the involvement of HAP1 and its binding proteins in potential functions.

Key words: HAP1, Huntington disease, huntingtin, transport

Introduction

Huntington disease (HD) is an inherited neurodegenerative disease caused by mutant Huntingtin (Htt) with cytosine-adenineguanine (CAG) trinucleotide repeats in exon 1 which codes for polyglutamine (polyQ) expansion.1 HD is characterized by cognitive decline, chorea, dementia and other psychiatric symptoms. Although the disease affects a number of brain regions such as the cortex, thalamus and subthalamic nuclei, the neuropathological hallmark of HD is the severe atrophy of the striatum.2,3 The normal Htt protein with 6 to 34 polyQ tract does not cause the disease whereas disease symptoms can be observed when polyQ extension is greater than 40 in the N-terminal fragment of Htt. Htt is ubiquitously expressed in the brain and peripheral organs.2 The polyQ region contributes to the modification of the three-dimensional structure of the whole protein and difference in the physiological reaction with other related proteins. This is why the number of ployQ repeat plays a key role in the disease pathogenesis.4

Hungtingtin-associated protein 1 (HAP1) was the first Htt interacting proteins to be identified in yeast two-hybrid screens.5 HAP1 binds more tightly to Htt with an expanded glutamine repeat than to wild type Htt, and the binding is enhanced by lengthening the glutamine repeat.6 Unlike Htt which is expressed ubiquitously, HAP1 is expressed predominantly in the central nervous system (CNS), particularly in the basal forebrain, cerebral cortex, cerebellum, the accessory olfactory bulb and the pedunculopontine nuclei, and highly expressed in the olfactory bulb, the hypothalamus, and the supraoptic nucleus.5,79 Rat HAP1 consists of two isoforms (HAP1-A, 75 Kd and HAP1-B, 85 Kd) which have different C-terminal sequences (amino acids 579–599 in HAP1-A and amino acids 579–629 in HAP1-B). HAP1-A has a unique sequence of 21 amino acids, whereas HAP1-B has a different sequence of 51 amino acids.5,10,11 The expression ratios of rat HAP1-A to HAP1-B are different in various regions. In the olfactory bulb and spinal cord, the level of HAP1-A is lower than that of HAP1-B.11 In the striatum and other regions their levels are almost the same.12 Human HAP1 is detected as only one major form (75 Kd) which shares a great similarity with HAP1-A mainly in the hippocampus and caudate, while the levels are lower in the cerebral cortex and cerebellum, and no expression is found in the thalamus and white matter.6,8,13

In investigating the function of two HAP1 isoforms, it was found that the common region of HAP1-A and HAP1-B binds to other molecules which constitute the cytoplasmic inclusions; however the C-terminus of HAP1-B takes the role for inhibition of the formation of inclusions whereas the unique C-terminal region of HAP1-A seems to be critical for inclusion formation. Both isoforms can aggregate in different proportions or self-associate in vivo, where HAP1-A accelerates the formation of inclusions and HAP1-B suppresses this formation simultaneously. Whether there are inclusions in the cell body depends on the proportion of the two isoforms.11 The dynamic association between the isoforms regulate the variable size of the inclusions in the body.11 The expression level of HAP1-B is normally higher than that of HAP1-A in most brain regions. This could explain in part why the majority of native HAP1 in the brain is cytosolic and diffusely distributed in the neurons.11

Like Htt, HAP1 is a cytoplasmic protein with neither conserved transmembrane domains nor nuclear localization signals,14 and associates with microtubules and many types of membraneous organelles, such as mitochondria, endoplasmic reticulum, tubulovesicles, endosomal and lysosomal organelles.15 In adult mouse brain neurons, HAP1 is highly enriched in large dense organelles, large endosomes (multivesicular bodies) and moderately locate in small vesicles, tubulovesicular structures, plasma membrane, coated and budding vesicles and microtubules.13 The localization of HAP1 and Htt is similar which suggests that HAP1 and Htt have the role in intracellular transport.15

As HAP1 is expressed more abundantly in the hypothalamus, which is well documented to regulate feeding behavior, the postnatal HAP1 knockout mice show suckling defects that ultimately leads to malnutrition, dehydration and premature death.1619 Nipple-searching behavior and attachment to the nipple, in most mammals, is believed to be mediated primarily by olfactory and tactile cues.20 Absence of olfactory bulbs or surgical lesions in the olfactory system in newborns lead to a reduction in nipple attachment efficiency, and consequent early postnatal lethality due to starvation.21 All HAP1 knock out pups exhibited a normal rooting reflex in response to manual stimulation of their mouth region, indicating normal tactile sensation and motor control. Moreover, HAP1 knock out pups' mothers do nest, crouch over their pups in a typical nursing manner, and collect them when they are scattered, further indicating that olfaction is not affected in HAP1 knock out mice.16

Htt act as a scaffold protein which enables the packaging of various proteins for transport along microtubules. As the binding protein of Htt, HAP1 is as one of the components of cargo-motor molecules and participates in intracellular trafficking.14,2225 The common region of both HAP1 isoforms contains three predicted coiled-coil domains,23,26 which may be responsible for binding with the interacting proteins, such as Htt (amino acids 171–230).27 In this review, we attempt to discuss all HAP1 interacting proteins discovered so far to explain the functions of HAP1 (Table 1). Based on the functions of these interacting proteins and the direct evidence revealed in the literature, HAP1 is likely involved in the vesicular transport, gene transcription regulation, membrane receptor trafficking and other functions such as calcium release and protein aggregation.

Table 1.

HAP1-interacting proteins

Name Function Region in HAP1 for binding Refs
Huntingtin Scaffold protein Amino acids 278–370 12
p150Glued Microtubule-dependent transporter Amino acids 278–445 12, 26
KLC Vesicular trafficking 24
GABAA receptors Membrane receptor Amino acids 220–520 47
TrkA Nerve growth factor receptor 25
Hrs Vesicular trafficking Amino acids 246–425 23
EGFR NeuroD(ND) Neuronal transcription factor Amino acids 247–446 64
InsP3R1 Membrane receptor Amino acids 273–599 in HAP1A 70
14-3-3 protein Multifunctional regulatory protein
Duo GDP-GTP exchange factor Animo acids 1–313 79
AR Androgen receptor 91
TBP Transcription factor 93
AHI1 Signal transduction, RNA processing, transcriptional regulation, 98
cytoskeleton assembly, vesicle trafficking and cell division

HAP1 Regulates Vesicular Transport by Interacting with Accessory Molecular Motor Proteins and the Signaling Molecules

Substantial evidence suggests that HAP1 plays important roles in the vesicular transport within neurons and axons. Li and Li have made an excellent review on this topic.14 Here in this review, we focus its roles in vesicular transport by elaborating different interacting molecules.

p150Glued.

p150Glued is the largest member of all the dynactin subunits. Dynactin is a multisubunit protein complex that binds to dynein which is the microtubule motor that participates in retrograde transport in cells.26 Dynactin binds dynein directly and allows the motor vehicle to travel over long distances.28 The N-terminal fragments of p150Glued contain a conserved CAP-Gly (cytoskeleton-associated protein, glycine-rich) motif which plays a very important role in dynactin binding to microtubules.2931 This motif also contributes to microtubule minus-end anchoring at interphase centrosomes and mitotic spindle poles.3234 In addition to microtubules, the p150Glued CAP-Gly domain binds proteins such as EB1 and CLIP-170, both of which are themselves microtubule-binding proteins.28 The middle region of p150Glued is responsible for interacting with microtubule-based motors.28

HAP1 binds to p150Glued and induces the microtubule-dependent retrograde transport of membranous organelles. HAP1 may influence the transport of various proteins that bind to p150Glued .12,26 From the colocalization experiment of HAP1 and p150Glued in transfected cells, the cytoplasmic inclusions were found to be colocalized with HAP1. Thus the cytoplasmic inclusions could be transported along microtubules with HAP1 and p150Glued.12 It is reported that the common region of HAP1 also binds to Htt and p150Glued and acts as a scaffold linking Htt to dynactin complex.12,35

Kinesin light chain (KLC).

Kinesins are the largest superfamily of microtubule-dependent motors for anterograde transport with 45 members in mice and human and they are the most abundant motors in many cell types. Conventional kinesin, kinesin I, was originally discovered in the context of vesicle transport in axons. It is a tetramer consisting of a kinesin heavy chain (KHC, 110–120 Kd) dimer and two kinesin light chains (KLC, 60–70 Kd).36,37 The N-terminal globular motor domain of KHC contains a microtubule-binding sequence and an ATP-binding sequence. The C-terminus has a unique sequence and is linked with the N-terminal coiled-coil domain of KLC.3841 The C-terminus of KLC consists of six tetratrico peptide repeat domains, which are involved in protein-protein interactions and are proposed to link KLC to receptor proteins on vesicular cargoes.42,43 This diversity of domains is thought to regulate motor activity and binding to different cargoes.44 HAP1 was found to interact with KLC that drives anterograde transport along microtubules in neuronal processes and HAP1 gene deletion suppressed kinesin-dependent transport of amyloid precursor protein vesicles. HAP1-A preferentially binds KLC as compared with HAP1-B.24 These findings demonstrate that HAP1 plays an accessory role not only in retrograde transport but also anterograde transport along microtubules.

14-3-3 protein.

The 14-3-3 family contains well conserved and ubiquitously expressed regulatory proteins. 14-3-3 proteins are multifunctional regulators, and they bind a large number of proteins, including cytoskeletal and trafficking proteins and are involved in the regulation of many crucial cellular processes, such as signal transduction and protein trafficking.45,46 Using the yeast two-hybrid system, HAP1 was found to interact with 14-3-3 proteins. The overexpressed 14-3-3 decreases the trafficking of HAP1-A to the neuronal processes and neurite tips and inhibits the function of HAP1-A in promoting neurite outgrowth.47

Duo.

Duo was identified by using the yeast two-hybrid system as one of HAP1-binding proteins, which is a membrane cytoskeletal protein48 and belongs to RhoGEF superfamily.49,50 Guanine exchange factors (GEF) stimulate Rho and Rac signal transduction by switching them from the inactive (GDP-bound) to the active (GTP-bound) form. These molecules are often involved in organizing the cytoskeleton and act as axon guidance molecules.51 Duo contains at least four or five spectrin-like repeats which enable it to bind to actin, one GEF domain,48,52 peptidylglycine α-amidating monooxygenase (PAM) binding region, and HAP1 binding region. The cytoplasmic domain of PAM, which binds Duo is believed to be involved in the biogenesis of secretory granules and has a sorting signal for internalization from the cell surface.53 Duo is a rac1-specific binding protein, which regulates cytoskeleton (actin) organization, endocytosis, exocytosis and free radical production. Thus HAP1 is proposed to play a role in vesicle trafficking and cytoskeletal functions, and takes part in a ras-related signaling pathway.50

Hepatocyte growth factor-regulated tyrosine kinase substrate (Hrs).

Hrs, a mammalian homologue of yeast vacuolar protein sorting protein Vps27p, contains a phosphatidylinositol 3-phosphate-binding FYVE domain and the association of Hrs with early endosomes was well established.5457 Hrs binds Vps23, recruiting ubiquitinated membrane proteins to form protein complexes called endosomal sorting complex required for transport (ESCRT) which transports endocytic membrane proteins to multiple vesicular bodies.58 HAP1 also interacts with Hrs, which plays a role in the regulation of vesicular trafficking and signal transduction,59,60 and regulates endocytic trafficking through early endosome.23 The association of HAP1 with Hrs is mediated via a coiled-coil interaction between the central coiled-coil domains of both proteins. HAP1 co-localizes with Hrs on early endosomes.23 The increased expression of mutant Htt causes abnormal interactions of HAP1 with Hrs, which results in aberrant endocytic trafficking.23,61

Abelson helper integration site 1 (AHI1).

Mouse AHI1 was initially identified as a common helper provirus integration site for murine leukemias and lymphomas.62 The protein encoded by the human AHI1 gene (AHI1 or Jouberin) contains 7 WD40 repeats, an SH3 domain, potential SH3 binding sites, and an N-terminal coiled-coiled domain.63 WD40 domains are present in proteins that are involved in a variety of functions, including signal transduction, RNA processing, transcriptional regulation, cytoskeleton assembly, vesicle trafficking and cell division.64 SH3 domains are a common feature of signalling molecules involved in numerous pathways.65 Using immunoprecipitation and mass spectrometry, mouse Ahi1 was found bound tightly to HAP1 and formed a stable protein complex in the brain. Ahi1 and HAP1 form a stable protein complex in vivo. HAP1 and Ahi1 stabilize each other and are important for maintaining the level of tyrosine kinase receptor B (TrkB) and BDNF signalling, which is critical for neuronal differentiation and cerebellar development.66

How HAP1 exactly regulates the vesicular transport is not fully understood. HAP1 clearly interacts with molecular motor accessory proteins which may directly holds cargos forward and backward. It may also likely interact with signaling molecules providing scaffold to interact with GTP-GDP exchangers which are necessary for vesicular fusion, fission and trafficking. HAP1 can interact with proteins such as 14-3-3 and Hrs which are known to have motives which directly interacts with membrane receptor proteins and regulates the membrane receptor trafficking.

HAP1 may Regulates Gene Transcription by Interacting with Transcription Factors

NeuroD (ND).

ND is a basic helix-loop-helix transcription factor important for regulation of neuronal development and survival in vertebrates.6769 Disruption of ND causes massive cell death in subsets of differentiating and mature neurons.6769 ND is also involved in the development and survival of pancreatic β cells and in the transcriptional activation of the insulin gene. Mutations in ND cause diabetes in mice and humans.67 By a yeast two-hybridization screen, ND was found to interact with Htt, HAP1 and mixed lineage kinase 2 (MLK2).67 MLK2 is a protein kinase that phosphorylates MKK4/7 and consequently activates the JNK signaling pathway.23,7072 MLK2 is also enriched in neurons and associated with Htt.72 Htt interacts with ND via HAP1, and Htt and HAP1 facilitate MLK2 phosphorylation which stimulates the activity of ND. This mechanism implicates Htt and HAP1 may play a role in transcriptional regulation by ND. This assumption requires further investigation.

TATA-binding protein (TBP).

Like HD and SBMA, Spinocerebellar ataxia 17 (SCA17) is also caused by expansions in the polyglutamine (polyQ) repeats in TBP. TBP is a general transcription factor that functions in initiation by all three nuclear RNA polymerase.73 Nuclear Htt aggregates typically contain proteasome subunits, chaperones and ubiquitin. Aggregates also contain transcription factors, including TBP.74 Using unbiased two-hybrid screens, TBP is found to interact with HAP1. The binding mapping shows that HAP1 has two regions (amino acids 157 and 261, amino acids 473 and 582) both bind the conserved C-terminal TBP domain.74 When HAP1 or TBP were expressed independently in COS-7, 293, or Neuro-2a cells, all TBP localizes to the nucleus and all HAP1 assembles into cytoplasmic stigmoid-like bodies (STLBs). When co-expressed, a portion of the TBP was assembled into the HAP1 positive STLBs while the remainder was localized to the nucleus. The HAP1 and TBP binding is not polyQ-length-dependent manner, but removal of the TBP Q repeat can reduce the proportion of TBP that is assembled into STLBs, whereas expansion of the Q (repeat) had no significant affect on TBP subcellular localization.74 However, whether HAP1 is involved in the expression of the genes regulated by TBP is yet to be determined.

HAP1 Regulates Recycling of Membrane Receptors and is Involved in the Signal Transduction

Recent evidences suggest that HAP1 may regulate the turnover and stabilization of membrane receptors on the cell surface to maintain neuronal responses to neurotransmitters and neurotrophic factors. HAP1 increases the levels of cell surface receptors by inhibition of lysosomal degradation pathway and enhances endocytic recycling pathways. Thus HAP1 may maintain neuronal transmission and neurotrophic functions on developing neurons by regulating receptor reccycling and degradation.

γ-aminobutyric acid type A receptors (GABAA receptors).

γ-aminobutyric acid type A receptors (GABAA receptors) regulate neuronal excitability by the level of stability on the cell surface.75,76 Most benzodiazepine-sensitive GABAA receptors are constructed from α, β and γ2 subunits.75,76 HAP1 binds the GABAAR β subunit specifically.77 Synaptic GABAA receptors are undergoing clathrin-dependent endocytosis.7880 Accordingly, the internalized GABAA receptor can be either recycled to the cell membrane surface or targeted for lysosomal degradation.14 During the cell signaling pathway of GABAAR, HAP1 inhibits the receptor lysosomal degradation and at the same time facilitates the receptor recycling back to the cell membrane. In this way, over expressed HAP1 increases GABAAR cell surface number, therefore increase the neuronal excitability.77 Suppression of HAP1 by siRNA decreases the level and activity of GABAA receptors in the hypothalamus. Food intake and body weight of mice was also reduced by the HAP1 siRNA and in HAP1 knockout mice.16,18 The inhibition of hypothalamic HAP1 expression elevated insulin circulation which in turn crucially decreases hypothalamic activity and feeding activity.18 These findings suggest that HAP1 might function as a mediator for regulating the activity of hypothalamic GABAA receptors in control of the feeding behavior.

TrkA.

Neurotrophins mainly activate two kinds of cell surface nerve growth factor receptors, the high affinity of tyrosine receptor kinase (Trk) family which includes three members, TrkA, TrkB and TrkC and the low affinity p75 neurotrophin receptor (p75NTR) which is a member of the tumor necrosis factor (TNF) receptor superfamily. In nerve terminals, endocytosis and trafficking of nerve growth factor receptors are essential for synaptic transmission and plasticity. The dynactin p150Glued or kinesin microtubule-dependent transporters participate in receptor internalization at nerve terminals.25,81 HAP1-A is phoshorylated on the C-terminal site. The phosphorylated HAP1-A binds less dynactin p150Glued and KLC than non-phosphorylated HAP1-A. Mutant Htt can affect kinesin- or dynactin-associated transport35,82,83 and inhibit neurite outgrowth. HAP1 maintains the normal level of membrane TrkA by preventing the degradation of internalized TrkA. HAP1 deficiency can reduce the level of TrkA and neurite outgrowth.25 HAP1 also increases the level of TrkB on cell surface by interacting with Ahi1 and regulates the development of cerebellum by maintaining BDNF/trkB signaling.65

HAP1 may regulate the turnover of epidermal growth factor receptor (EGFR) which is highly expressed in the developing brain and important for neuronal survival84,85 and proliferation.86 Overexpression of HAP1 prevents the trafficking of internalized EGFR from early endosomes to lysosomes, and in turn suppresses ligand-induced degradation of internalized EGFR.61 Inhibition of HAP1 expression decreases EGRF signaling and cell viability, whereas overexpression HAP1 enhances this signaling activity and inhibits mutant Htt mediated cytotoxicity.61

The type 1 inositol (1,4,5)-triphosphate receptor (InsP3R1).

The type 1 inositol (1,4,5)-trisphosphate receptor (InsP3R1) is another membrane receptor that also binds to HAP1.87 InsP3R1 is an intracellular Ca2+ release channel which is very important in the neuronal Ca2+ signal pathway.88 Htt could directly interact with the InsP3R1 C-terminus and the binding of Htt to the InsP3R1 C-terminus is dependent on both the presence of HAP1 and the polyQ expansion. Mutant Htt can bind to the InsP3R1 C-terminus either directly or indirectly through HAP1.89 But the interesting finding is that the functional effects of mutant Htt on InsP3R1-mediated Ca2+ release are attenuated in medium spiny striatal neurons (MSN) of HAP1 knockout mice when compared with wild-type mice MSN. Thus, HAP1 potentiates functional effects of mutant Htt on InsP3R1 function in vivo. As already known, increases in neuronal Ca2+ represent early events in the pathogenesis of HD.87,90

Androgen receptor (AR).

Human AR gene has been reported to have a CAG-repeat motif near its 5′-terminus, as Htt, being translated to AR protein with a polyQ sequence near the N-terminus.91 Another distinct polyQ-neurodegenerative disease, spinal and bulbar muscular atrophy (SBMA) [Kennedy disease or Kennedy-Alter-Sung syndrome (KAS)], is elicits by polyQ AR.92,93 Like Htt, HAP1 interacts with AR in an AR-polyQ-length-dependent manner in HEp-2 cells cotransfected with HAP1 and/or normal ARQ25, SBMA-mutant ARQ65 or deletion-mutant AR cDNAs, and forms prominent cytoplasmic aggregations sequestering AR. HAP1 has a higher binding affinity with ARQ65 than ARQ25. The overexpressed HAP1 can rescue the SBMA-mutant-ARQ65-induced apoptosis.93

HAP1 may Play a Role in the Generation of Inclusion Bodies

A number of reports show that the overexpression of HAP1 in vitro results in the formation of cytoplasmic inclusions,74,93 suggesting that HAP1 directs assembly of similar cytoplasmic inclusions in neuronal and non-neuronal cell types. In the physiological condition, HAP1 is also found to associate with in large inclusion bodies.11,15 One of these types of aggregates called Stigmoid Bodies (SBs). The SBs are structures found in the cytoplasm of various types of neurons in the central and peripheral nervous system.9496 They are distinct, spherical-to-ovoidal and non-membrane-bound neuronal cytoplasmic inclusions (∼0.5–3 µm in diameter) with a granulo-fuzzy texture and moderate-to-low electron density,97 and are found abundantly in the preoptic, hypothalamic and limbic forebrain regions of the rat.98 Although the subcellular functions of SBs have not yet been understood, it is important to know that SBs contain HAP1.11,15 SBs containing HAP1 also are found to contain the unknown human placental antigen complex X-P2 (hPAX-P2) and apolipoprotein E receptor, SorLA/LR11 and sortilin (two members of the vacuolar protein sorting 10 (VPS10) domain-containing family).9496 HAP1 is a core component of the SBs and important for fetal and early postnatal neural development, particularly in the hypothalamic or limbic networks and HAP1/SBs has been assumed to play a protective role against neurodegeneration in HD.96,99 Whether HAP1 plays any role in the pathological protein aggregation such as in Alzheimer disease, Parkinson disease and Huntington disease is not clear.

Concluding Remarks

In conclusion, HAP1 plays critical role in the trafficking of intracellular organelles and membrane proteins by interacting with a number of proteins. HAP1 acts as an accessary molecule for microtubule associated molecular motors carrying related cargos towards both plus and minors ends of microtubules, maintaining normal cellular functions such as calcium homeostasis, neurite growth, neurotrophic functions, neuronal differentiation and synaptic transmission and plasticity. The polyQ expansion mutations on the N-termini of several proteins such as Htt, AR and TBP may alter the interaction property of HAP1 with these proteins, leading to dysfunctions of intracellular cargo trafficking and neurodegeneration. HAP1 may also participate in the regulation of gene expression by interacting with transcription factors. Further characterization of HAP1 functions will provide precise molecular targets for the treatment of neurodegenerative diseases resulted from these dysfunctions of protein-protein interactions.

Acknowledgements

This work is supported by grants from the NIHMRC (375109, 375110).

Footnotes

Previously published online as a Cell Adhesion & Migration E-publication: http://www.landesbioscience.com/journals/celladhesion/article/7511

References

  • 1.A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group. Cell. 1993;72:971–983. doi: 10.1016/0092-8674(93)90585-e. [DOI] [PubMed] [Google Scholar]
  • 2.Davies S, Ramsden DB. Huntington's disease. Mol Pathol. 2001;54:409–413. doi: 10.1136/mp.54.6.409. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Cattaneo E, Zuccato C, Tartari M. Normal huntingtin function: an alternative approach to Huntington's disease. Nat Rev Neurosci. 2005;6:919–930. doi: 10.1038/nrn1806. [DOI] [PubMed] [Google Scholar]
  • 4.Poirier MA, Jiang H, Ross CA. A structure-based analysis of huntingtin mutant polyglutamine aggregation and toxicity: evidence for a compact beta-sheet structure. Hum Mol Genet. 2005;14:765–774. doi: 10.1093/hmg/ddi071. [DOI] [PubMed] [Google Scholar]
  • 5.Li XJ, Li SH, Sharp AH, Nucifora FC, Jr, Schilling G, Lanahan A, et al. A huntingtinassociated protein enriched in brain with implications for pathology. Nature. 1995;378:398–402. doi: 10.1038/378398a0. [DOI] [PubMed] [Google Scholar]
  • 6.Li SH, Hosseini SH, Gutekunst CA, Hersch SM, Ferrante RJ, Li XJ. A human HAP1 homologue. Cloning, expression and interaction with huntingtin. J Biol Chem. 1998;273:19220–19227. doi: 10.1074/jbc.273.30.19220. [DOI] [PubMed] [Google Scholar]
  • 7.Page KJ, Potter L, Aronni S, Everitt BJ, Dunnett SB. The expression of Huntingtinassociated protein (HAP1) mRNA in developing, adult and ageing rat CNS: implications for Huntington's disease neuropathology. Eur J Neurosci. 1998;10:1835–1845. doi: 10.1046/j.1460-9568.1998.00185.x. [DOI] [PubMed] [Google Scholar]
  • 8.Li XJ, Sharp AH, Li SH, Dawson TM, Snyder SH, Ross CA. Huntingtin-associated protein (HAP1): discrete neuronal localizations in the brain resemble those of neuronal nitric oxide synthase. Proc Natl Acad Sci USA. 1996;93:4839–4844. doi: 10.1073/pnas.93.10.4839. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Dragatsis I, Dietrich P, Zeitlin S. Expression of the Huntingtin-associated protein 1 gene in the developing and adult mouse. Neurosci Lett. 2000;282:37–40. doi: 10.1016/s0304-3940(00)00872-7. [DOI] [PubMed] [Google Scholar]
  • 10.Nasir J, Duan K, Nichol K, Engelender S, Ashworth R, Colomer V, et al. Gene structure and map location of the murine homolog of the Huntington-associated protein, Hap1. Mamm Genome. 1998;9:565–570. doi: 10.1007/s003359900819. [DOI] [PubMed] [Google Scholar]
  • 11.Li SH, Gutekunst CA, Hersch SM, Li XJ. Association of HAP1 isoforms with a unique cytoplasmic structure. J Neurochem. 1998;71:2178–2185. doi: 10.1046/j.1471-4159.1998.71052178.x. [DOI] [PubMed] [Google Scholar]
  • 12.Li SH, Gutekunst CA, Hersch SM, Li XJ. Interaction of huntingtin-associated protein with dynactin p150Glued. J Neurosci. 1998;18:1261–1269. doi: 10.1523/JNEUROSCI.18-04-01261.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Martin EJ, Kim M, Velier J, Sapp E, Lee HS, Laforet G, et al. Analysis of Huntingtin-associated protein 1 in mouse brain and immortalized striatal neurons. J Comp Neurol. 1999;403:421–430. [PubMed] [Google Scholar]
  • 14.Li XJ, Li SH. HAP1 and intracellular trafficking. Trends Pharmacol Sci. 2005;26:1–3. doi: 10.1016/j.tips.2004.11.001. [DOI] [PubMed] [Google Scholar]
  • 15.Gutekunst CA, Li SH, Yi H, Ferrante RJ, Li XJ, Hersch SM. The cellular and subcellular localization of huntingtin-associated protein 1 (HAP1): comparison with huntingtin in rat and human. J Neurosci. 1998;18:7674–7686. doi: 10.1523/JNEUROSCI.18-19-07674.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Dragatsis I, Zeitlin S, Dietrich P. Huntingtin-associated protein 1 (Hap1) mutant mice bypassing the early postnatal lethality are neuroanatomically normal and fertile but display growth retardation. Hum Mol Genet. 2004;13:3115–3125. doi: 10.1093/hmg/ddh328. [DOI] [PubMed] [Google Scholar]
  • 17.Chan EY, Nasir J, Gutekunst CA, Coleman S, Maclean A, Maas A, et al. Targeted disruption of Huntingtin-associated protein-1 (Hap1) results in postnatal death due to depressed feeding behavior. Hum Mol Genet. 2002;11:945–959. doi: 10.1093/hmg/11.8.945. [DOI] [PubMed] [Google Scholar]
  • 18.Sheng G, Chang GQ, Lin JY, Yu ZX, Fang ZH, Rong J, et al. Hypothalamic huntingtin-associated protein 1 as a mediator of feeding behavior. Nat Med. 2006;12:526–533. doi: 10.1038/nm1382. [DOI] [PubMed] [Google Scholar]
  • 19.Woods SC, Seeley RJ. Hap1 and GABA: thinking about food intake. Cell Metab. 2006;3:388–390. doi: 10.1016/j.cmet.2006.05.007. [DOI] [PubMed] [Google Scholar]
  • 20.Larson MA, Stein BE. The use of tactile and olfactory cues in neonatal orientation and localization of the nipple. Dev Psychobiol. 1984;17:423–436. doi: 10.1002/dev.420170408. [DOI] [PubMed] [Google Scholar]
  • 21.Hongo T, Hakuba A, Shiota K, Naruse I. Suckling dysfunction caused by defects in the olfactory system in genetic arhinencephaly mice. Biol Neonate. 2000;78:293–299. doi: 10.1159/000014282. [DOI] [PubMed] [Google Scholar]
  • 22.Gunawardena S, Goldstein LS. Cargo-carrying motor vehicles on the neuronal highway: transport pathways and neurodegenerative disease. J Neurobiol. 2004:258–271. doi: 10.1002/neu.10319. [DOI] [PubMed] [Google Scholar]
  • 23.Li Y, Chin LS, Levey AI, Li L. Huntingtin-associated protein 1 interacts with hepatocyte growth factor-regulated tyrosine kinase substrate and functions in endosomal trafficking. J Biol Chem. 2002;277:28212–28221. doi: 10.1074/jbc.M111612200. [DOI] [PubMed] [Google Scholar]
  • 24.McGuire JR, Rong J, Li SH, Li XJ. Interaction of Huntingtin-associated protein-1 with kinesin light chain: implications in intracellular trafficking in neurons. J Biol Chem. 2006;281:3552–3559. doi: 10.1074/jbc.M509806200. [DOI] [PubMed] [Google Scholar]
  • 25.Rong J, McGuire JR, Fang ZH, Sheng G, Shin JY, Li SH, et al. Regulation of intracellular trafficking of huntingtin-associated protein-1 is critical for TrkA protein levels and neurite outgrowth. J Neurosci. 2006;26:6019–6030. doi: 10.1523/JNEUROSCI.1251-06.2006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Engelender S, Sharp AH, Colomer V, Tokito MK, Lanahan A, Worley P, et al. Huntingtin-associated protein 1 (HAP1) interacts with the p150Glued subunit of dynactin. Hum Mol Genet. 1997;6:2205–2212. doi: 10.1093/hmg/6.13.2205. [DOI] [PubMed] [Google Scholar]
  • 27.Bertaux F, Sharp AH, Ross CA, Lehrach H, Bates GP, Wanker E. HAP1-huntingtin interactions do not contribute to the molecular pathology in Huntington's disease transgenic mice. FEBS Lett. 1998;426:229–232. doi: 10.1016/s0014-5793(98)00352-4. [DOI] [PubMed] [Google Scholar]
  • 28.Schroer TA. Dynactin. Annu Rev Cell Dev Biol. 2004;20:759–779. doi: 10.1146/annurev.cellbio.20.012103.094623. [DOI] [PubMed] [Google Scholar]
  • 29.Riehemann K, Sorg C. Sequence homologies between four cytoskeleton-associated proteins. Trends Biochem Sci. 1993;18:82–83. doi: 10.1016/0968-0004(93)90159-k. [DOI] [PubMed] [Google Scholar]
  • 30.Waterman-Storer CM, Karki S, Holzbaur EL. The p150Glued component of the dynactin complex binds to both microtubules and the actin-related protein centractin (Arp-1) Proc Natl Acad Sci USA. 1995;92:1634–1638. doi: 10.1073/pnas.92.5.1634. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Vaughan PS, Miura P, Henderson M, Byrne B, Vaughan KT. A role for regulated binding of p150(Glued) to microtubule plus ends in organelle transport. J Cell Biol. 2002;158:305–319. doi: 10.1083/jcb.200201029. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Quintyne NJ, Gill SR, Eckley DM, Crego CL, Compton DA, Schroer TA. Dynactin is required for microtubule anchoring at centrosomes. J Cell Biol. 1999;147:321–334. doi: 10.1083/jcb.147.2.321. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Quintyne NJ, Schroer TA. Distinct cell cycle-dependent roles for dynactin and dynein at centrosomes. J Cell Biol. 2002;159:245–254. doi: 10.1083/jcb.200203089. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Gaglio T, Dionne MA, Compton DA. Mitotic spindle poles are organized by structural and motor proteins in addition to centrosomes. J Cell Biol. 1997;138:1055–1066. doi: 10.1083/jcb.138.5.1055. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Gauthier LR, Charrin BC, Borrell-Pages M, Dompierre JP, Rangone H, Cordelieres FP, et al. Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules. Cell. 2004;118:127–138. doi: 10.1016/j.cell.2004.06.018. [DOI] [PubMed] [Google Scholar]
  • 36.Bloom GS, Wagner MC, Pfister KK, Brady ST. Native structure and physical properties of bovine brain kinesin and identification of the ATP-binding subunit polypeptide. Biochemistry. 1988;27:3409–3416. doi: 10.1021/bi00409a043. [DOI] [PubMed] [Google Scholar]
  • 37.Kuznetsov SA, Vaisberg EA, Shanina NA, Magretova NN, Chernyak VY, Gelfand VI. The quaternary structure of bovine brain kinesin. EMBO J. 1988;7:353–356. doi: 10.1002/j.1460-2075.1988.tb02820.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Hirokawa N, Sato-Yoshitake R, Kobayashi N, Pfister KK, Bloom GS, Brady ST. Kinesin associates with anterogradely transported membranous organelles in vivo. J Cell Biol. 1991;114:295–302. doi: 10.1083/jcb.114.2.295. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Pfister KK, Wagner MC, Stenoien DL, Brady ST, Bloom GS. Monoclonal antibodies to kinesin heavy and light chains stain vesicle-like structures, but not microtubules, in cultured cells. J Cell Biol. 1989;108:1453–1463. doi: 10.1083/jcb.108.4.1453. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Yang JT, Saxton WM, Stewart RJ, Raff EC, Goldstein LS. Evidence that the head of kinesin is sufficient for force generation and motility in vitro. Science. 1990;249:42–47. doi: 10.1126/science.2142332. [DOI] [PubMed] [Google Scholar]
  • 41.Scholey JM, Heuser J, Yang JT, Goldstein LS. Identification of globular mechanochemical heads of kinesin. Nature. 1989;338:355–357. doi: 10.1038/338355a0. [DOI] [PubMed] [Google Scholar]
  • 42.Schnapp BJ. Trafficking of signaling modules by kinesin motors. J Cell Sci. 2003;116:2125–2135. doi: 10.1242/jcs.00488. [DOI] [PubMed] [Google Scholar]
  • 43.Hirokawa N, Takemura R. Molecular motors and mechanisms of directional transport in neurons. Nat Rev Neurosci. 2005;6:201–214. doi: 10.1038/nrn1624. [DOI] [PubMed] [Google Scholar]
  • 44.Vale RD. The molecular motor toolbox for intracellular transport. Cell. 2003;112:467–480. doi: 10.1016/s0092-8674(03)00111-9. [DOI] [PubMed] [Google Scholar]
  • 45.Pozuelo Rubio M, Geraghty KM, Wong BH, Wood NT, Campbell DG, Morrice N, et al. 14-3-3-affinity purification of over 200 human phosphoproteins reveals new links to regulation of cellular metabolism, proliferation and trafficking. Biochem J. 2004;379:395–408. doi: 10.1042/BJ20031797. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Jin J, Smith FD, Stark C, Wells CD, Fawcett JP, Kulkarni S, et al. Proteomic, functional and domain-based analysis of in vivo 14-3-3 binding proteins involved in cytoskeletal regulation and cellular organization. Curr Biol. 2004;14:1436–1450. doi: 10.1016/j.cub.2004.07.051. [DOI] [PubMed] [Google Scholar]
  • 47.Rong J, Li S, Sheng G, Wu M, Coblitz B, Li M, et al. 14-3-3 protein interacts with Huntingtin-associated protein 1 and regulates its trafficking. J Biol Chem. 2007;282:4748–4756. doi: 10.1074/jbc.M609057200. [DOI] [PubMed] [Google Scholar]
  • 48.Goodman SR, Zimmer WE, Clark MB, Zagon IS, Barker JE, Bloom ML. Brain spectrin: of mice and men. Brain Res Bull. 1995;36:593–606. doi: 10.1016/0361-9230(94)00264-2. [DOI] [PubMed] [Google Scholar]
  • 49.Erickson JW, Cerione RA. Structural elements, mechanism and evolutionary convergence of Rho protein-guanine nucleotide exchange factor complexes. Biochemistry. 2004;43:837–842. doi: 10.1021/bi036026v. [DOI] [PubMed] [Google Scholar]
  • 50.Colomer V, Engelender S, Sharp AH, Duan K, Cooper JK, Lanahan A, et al. Huntingtin-associated protein 1 (HAP1) binds to a Trio-like polypeptide, with a rac1 guanine nucleotide exchange factor domain. Hum Mol Genet. 1997;6:1519–1525. doi: 10.1093/hmg/6.9.1519. [DOI] [PubMed] [Google Scholar]
  • 51.Schmidt A, Hall A. Guanine nucleotide exchange factors for Rho GTPases: turning on the switch. Genes Dev. 2002;16:1587–1609. doi: 10.1101/gad.1003302. [DOI] [PubMed] [Google Scholar]
  • 52.Matsudaira P. Modular organization of actin crosslinking proteins. Trends Biochem Sci. 1991;16:87–92. doi: 10.1016/0968-0004(91)90039-x. [DOI] [PubMed] [Google Scholar]
  • 53.Milgram SL, Mains RE, Eipper BA. Identification of routing determinants in the cytosolic domain of a secretory granule-associated integral membrane protein. J Biol Chem. 1996;271:17526–17535. doi: 10.1074/jbc.271.29.17526. [DOI] [PubMed] [Google Scholar]
  • 54.Chin LS, Raynor MC, Wei X, Chen HQ, Li L. Hrs interacts with sorting nexin 1 and regulates degradation of epidermal growth factor receptor. J Biol Chem. 2001;276:7069–7078. doi: 10.1074/jbc.M004129200. [DOI] [PubMed] [Google Scholar]
  • 55.Komada M, Masaki R, Yamamoto A, Kitamura N. Hrs, a tyrosine kinase substrate with a conserved double zinc finger domain, is localized to the cytoplasmic surface of early endosomes. J Biol Chem. 1997;272:20538–20544. doi: 10.1074/jbc.272.33.20538. [DOI] [PubMed] [Google Scholar]
  • 56.Raiborg C, Bremnes B, Mehlum A, Gillooly DJ, D'Arrigo A, Stang E, et al. FYVE and coiled-coil domains determine the specific localisation of Hrs to early endosomes. J Cell Sci. 2001;114:2255–2263. doi: 10.1242/jcs.114.12.2255. [DOI] [PubMed] [Google Scholar]
  • 57.Urbe S, Mills IG, Stenmark H, Kitamura N, Clague MJ. Endosomal localization and receptor dynamics determine tyrosine phosphorylation of hepatocyte growth factor-regulated tyrosine kinase substrate. Mol Cell Biol. 2000;20:7685–7692. doi: 10.1128/mcb.20.20.7685-7692.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Nickerson DP, Russell MR, Odorizzi G. A concentric circle model of multivesicular body cargo sorting. EMBO reports. 2007;8:644–650. doi: 10.1038/sj.embor.7401004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Komada M, Kitamura N. Hrs and hbp: possible regulators of endocytosis and exocytosis. Biochem Biophys Res Commun. 2001;281:1065–1069. doi: 10.1006/bbrc.2001.4441. [DOI] [PubMed] [Google Scholar]
  • 60.Raiborg C, Bache KG, Mehlum A, Stenmark H. Function of Hrs in endocytic trafficking and signalling. Biochem Soc Trans. 2001;29:472–475. doi: 10.1042/bst0290472. [DOI] [PubMed] [Google Scholar]
  • 61.Li SH, Yu ZX, Li CL, Nguyen HP, Zhou YX, Deng C, et al. Lack of huntingtin-associated protein-1 causes neuronal death resembling hypothalamic degeneration in Huntington's disease. J Neurosci. 2003;23:6956–6964. doi: 10.1523/JNEUROSCI.23-17-06956.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Poirier Y, Jolicoeur P. Distinct helper virus requirements for Abelson murine leukemia virus-induced pre-B- and T-cell lymphomas. J Virol. 1989;63:2088–2098. doi: 10.1128/jvi.63.5.2088-2098.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Jiang X, Hanna Z, Kaouass M, Girard L, Jolicoeur P. Ahi-1, a novel gene encoding a modular protein with WD40-repeat and SH3 domains, is targeted by the Ahi-1 and Mis-2 provirus integrations. J Virol. 2002;76:9046–9059. doi: 10.1128/JVI.76.18.9046-9059.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Smith TF, Gaitatzes C, Saxena K, Neer EJ. The WD repeat: a common architecture for diverse functions. Trends Biochem Sci. 1999;24:181–185. doi: 10.1016/s0968-0004(99)01384-5. [DOI] [PubMed] [Google Scholar]
  • 65.Mayer BJ. SH3 domains: complexity in moderation. J Cell Sci. 2001;114:1253–1263. doi: 10.1242/jcs.114.7.1253. [DOI] [PubMed] [Google Scholar]
  • 66.Sheng G, Xu X, Lin YF, Wang CE, Rong J, Cheng D, et al. Huntingtin-associated protein 1 interacts with Ahi1 to regulate cerebellar and brainstem development in mice. J Clin Invest. 2008;118:2785–2795. doi: 10.1172/JCI35339. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67.Marcora E, Gowan K, Lee JE. Stimulation of NeuroD activity by huntingtin and huntingtin-associated proteins HAP1 and MLK2. Proc Natl Acad Sci USA. 2003;100:9578–9583. doi: 10.1073/pnas.1133382100. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68.Pennesi ME, Cho JH, Yang Z, Wu SH, Zhang J, Wu SM, et al. BETA2/NeuroD1 null mice: a new model for transcription factor-dependent photoreceptor degeneration. J Neurosci. 2003;23:453–461. doi: 10.1523/JNEUROSCI.23-02-00453.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69.Kim WY, Fritzsch B, Serls A, Bakel LA, Huang EJ, Reichardt LF, et al. NeuroD-null mice are deaf due to a severe loss of the inner ear sensory neurons during development. Development. 2001;128:417–426. doi: 10.1242/dev.128.3.417. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70.Velier J, Kim M, Schwarz C, Kim TW, Sapp E, Chase K, Aronin N, et al. Wild-type and mutant huntingtins function in vesicle trafficking in the secretory and endocytic pathways. Exp Neurol. 1998;152:34–40. doi: 10.1006/exnr.1998.6832. [DOI] [PubMed] [Google Scholar]
  • 71.Gallo KA, Johnson GL. Mixed-lineage kinase control of JNK and p38 MAPK pathways. Nat Rev Mol Cell Biol. 2002;3:663–672. doi: 10.1038/nrm906. [DOI] [PubMed] [Google Scholar]
  • 72.Liu YF, Dorow D, Marshall J. Activation of MLK2-mediated signaling cascades by polyglutamine-expanded huntingtin. J Biol Chem. 2000;275:19035–19040. doi: 10.1074/jbc.C000180200. [DOI] [PubMed] [Google Scholar]
  • 73.Hernandez N. TBP, a universal eukaryotic transcription factor? Genes Dev. 1993;7:1291–1308. doi: 10.1101/gad.7.7b.1291. [DOI] [PubMed] [Google Scholar]
  • 74.Prigge JR, Schmidt EE. HAP1 can sequester a subset of TBP in cytoplasmic inclusions via specific interaction with the conserved TBP(CORE) BMC Mol Biol. 2007;8:76. doi: 10.1186/1471-2199-8-76. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 75.Moss SJ, Smart TG. Constructing inhibitory synapses. Nat Rev Neurosci. 2001;2:240–250. doi: 10.1038/35067500. [DOI] [PubMed] [Google Scholar]
  • 76.Sieghart W, Sperk G. Subunit composition, distribution and function of GABA(A) receptor subtypes. Curr Top Med Chem. 2002;2:795–816. doi: 10.2174/1568026023393507. [DOI] [PubMed] [Google Scholar]
  • 77.Kittler JT, Thomas P, Tretter V, Bogdanov YD, Haucke V, Smart TG, et al. Huntingtin-associated protein 1 regulates inhibitory synaptic transmission by modulating gamma-aminobutyric acid type A receptor membrane trafficking. Proc Natl Acad Sci USA. 2004;101:12736–12741. doi: 10.1073/pnas.0401860101. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 78.Kittler JT, Moss SJ. Modulation of GABAA receptor activity by phosphorylation and receptor trafficking: implications for the efficacy of synaptic inhibition. Curr Opin Neurobiol. 2003;13:341–347. doi: 10.1016/s0959-4388(03)00064-3. [DOI] [PubMed] [Google Scholar]
  • 79.Herring D, Huang R, Singh M, Robinson LC, Dillon GH, Leidenheimer NJ. Constitutive GABAA receptor endocytosis is dynamin-mediated and dependent on a dileucine AP2 adaptin-binding motif within the beta2 subunit of the receptor. J Biol Chem. 2003;278:24046–24052. doi: 10.1074/jbc.M301420200. [DOI] [PubMed] [Google Scholar]
  • 80.Kittler JT, Delmas P, Jovanovic JN, Brown DA, Smart TG, Moss SJ. Constitutive endocytosis of GABAA receptors by an association with the adaptin AP2 complex modulates inhibitory synaptic currents in hippocampal neurons. J Neurosci. 2000;20:7972–7977. doi: 10.1523/JNEUROSCI.20-21-07972.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 81.Bananis E, Nath S, Gordon K, Satir P, Stockert RJ, Murray JW, et al. Microtubule-dependent movement of late endocytic vesicles in vitro: requirements for Dynein and Kinesin. Mol Biol Cell. 2004;15:3688–3697. doi: 10.1091/mbc.E04-04-0278. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 82.Gunawardena S, Her LS, Brusch RG, Laymon RA, Niesman IR, Gordesky-Gold B, et al. Disruption of axonal transport by loss of huntingtin or expression of pathogenic polyQ proteins in Drosophila. Neuron. 2003;40:25–40. doi: 10.1016/s0896-6273(03)00594-4. [DOI] [PubMed] [Google Scholar]
  • 83.Trushina E, Dyer RB, Badger JD, 2nd, Ure D, Eide L, Tran DD, et al. Mutant huntingtin impairs axonal trafficking in mammalian neurons in vivo and in vitro. Mol Cell Biol. 2004;24:8195–8209. doi: 10.1128/MCB.24.18.8195-8209.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 84.Kornblum HI, Hussain R, Wiesen J, Miettinen P, Zurcher SD, Chow K, et al. Abnormal astrocyte development and neuronal death in mice lacking the epidermal growth factor receptor. J Neurosci Res. 1998;53:697–717. doi: 10.1002/(SICI)1097-4547(19980915)53:6<697::AID-JNR8>3.0.CO;2-0. [DOI] [PubMed] [Google Scholar]
  • 85.Sibilia M, Steinbach JP, Stingl L, Aguzzi A, Wagner EF. A strain-independent postnatal neurodegeneration in mice lacking the EGF receptor. EMBO J. 1998;17:719–731. doi: 10.1093/emboj/17.3.719. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 86.Wang Y, Pennock S, Chen X, Wang Z. Endosomal signaling of epidermal growth factor receptor stimulates signal transduction pathways leading to cell survival. Mol Cell Biol. 2002;22:7279–7290. doi: 10.1128/MCB.22.20.7279-7290.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 87.Tang TS, Tu H, Chan EY, Maximov A, Wang Z, Wellington CL, et al. Huntingtin and huntingtin-associated protein 1 influence neuronal calcium signaling mediated by inositol-(1,4,5) triphosphate receptor type 1. Neuron. 2003;39:227–239. doi: 10.1016/s0896-6273(03)00366-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 88.Berridge MJ. Neuronal calcium signaling. Neuron. 1998;21:13–26. doi: 10.1016/s0896-6273(00)80510-3. [DOI] [PubMed] [Google Scholar]
  • 89.Tang TS, Tu H, Orban PC, Chan EY, Hayden MR, Bezprozvanny I. HAP1 facilitates effects of mutant huntingtin on inositol 1,4,5-trisphosphate-induced Ca release in primary culture of striatal medium spiny neurons. Eur J Neurosci. 2004;20:1779–1787. doi: 10.1111/j.1460-9568.2004.03633.x. [DOI] [PubMed] [Google Scholar]
  • 90.Zeron MM, Hansson O, Chen N, Wellington CL, Leavitt BR, Brundin P, et al. Increased sensitivity to N-methyl-D-aspartate receptor-mediated excitotoxicity in a mouse model of Huntington's disease. Neuron. 2002;33:849–860. doi: 10.1016/s0896-6273(02)00615-3. [DOI] [PubMed] [Google Scholar]
  • 91.Sleddens HF, Oostra BA, Brinkmann AO, Trapman J. Trinucleotide repeat polymorphism in the androgen receptor gene (AR) Nucleic Acids Res. 1992;20:1427. doi: 10.1093/nar/20.6.1427-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 92.Katsuno M, Adachi H, Tanaka F, Sobue G. Spinal and bulbar muscular atrophy: liganddependent pathogenesis and therapeutic perspectives. J Mol Med. 2004;82:298–307. doi: 10.1007/s00109-004-0530-7. [DOI] [PubMed] [Google Scholar]
  • 93.Takeshita Y, Fujinaga R, Zhao C, Yanai A, Shinoda K. Huntingtin-associated protein 1 (HAP1) interacts with androgen receptor (AR) and suppresses SBMA-mutant-AR-induced apoptosis. Hum Mol Genet. 2006;15:2298–2312. doi: 10.1093/hmg/ddl156. [DOI] [PubMed] [Google Scholar]
  • 94.Gutekunst CA, Torre ER, Sheng Z, Yi H, Coleman SH, Riedel IB, et al. Stigmoid bodies contain type I receptor proteins SorLA/LR11 and sortilin: new perspectives on their function. J Histochem Cytochem. 2003;51:841–852. doi: 10.1177/002215540305100615. [DOI] [PubMed] [Google Scholar]
  • 95.Torre ER, Coleman S, Yi H, Gutekunst CA. A protocol for isolation and biochemical characterization of stigmoid bodies from rat brain. J Neurosci Methods. 2003;125:27–32. doi: 10.1016/s0165-0270(03)00026-8. [DOI] [PubMed] [Google Scholar]
  • 96.Fujinaga R, Yanai A, Nakatsuka H, Yoshida K, Takeshita Y, Uozumi K, et al. Anti-human placental antigen complex X-P2 (hPAX-P2) anti-serum recognizes C-terminus of huntingtin-associated protein 1A common to 1B as a determinant marker for the stigmoid body. Histochem Cell Biol. 2007;128:335–348. doi: 10.1007/s00418-007-0315-5. [DOI] [PubMed] [Google Scholar]
  • 97.Shinoda K, Nagano M, Osawa Y. An aromatase-associated cytoplasmic inclusion, the “stigmoid body,” in the rat brain: II. Ultrastructure (with a review of its history and nomenclature) J Comp Neurol. 1993;329:1–19. doi: 10.1002/cne.903290102. [DOI] [PubMed] [Google Scholar]
  • 98.Shinoda K, Mori S, Ohtsuki T, Osawa Y. An aromatase-associated cytoplasmic inclusion, the “stigmoid body,” in the rat brain: I. Distribution in the forebrain. J Comp Neurol. 1992;322:360–376. doi: 10.1002/cne.903220306. [DOI] [PubMed] [Google Scholar]
  • 99.Fujinaga R, Kawano J, Matsuzaki Y, Kamei K, Yanai A, Sheng Z, et al. Neuroanatomical distribution of Huntingtin-associated protein 1-mRNA in the male mouse brain. J Comp Neurol. 2004;478:88–109. doi: 10.1002/cne.20277. [DOI] [PubMed] [Google Scholar]

Articles from Cell Adhesion & Migration are provided here courtesy of Taylor & Francis

RESOURCES